Tirzepatide currently being a twin GLP-1 and GIP agonist, it is proposed which the GIP component of twin agonism could be to blame for the extra profit, offered the potential benefit of GIP receptor agonism on peripheral insulin sensitization. Therefore, tirzepatide was more practical than dulaglutide in lessening fasting dietary TAG [six,seven].t